Use of intravenous immunoglobulin for the treatment of severe clostridium difficile colitis

American Journal Geriatric Pharmacotherapy

Volumn 5, Issue 1, 2007, Pages 48-51

  Hassoun, Ali ^a   Ibrahim, Farrah ^b  

^a Alabama Infectious Diseases Center   (United States)

^b UNIVERSITY OF ALABAMA IN HUNTSVILLE   (United States)

Author keywords

Clostridium difficile; colitis; elderly; immunoglobulin therapy

Indexed keywords

ESOMEPRAZOLE; HUMAN ALBUMIN; IMMUNOGLOBULIN G; LEVOFLOXACIN; METRONIDAZOLE; NITAZOXANIDE; PARACETAMOL; STEROID; THYROXINE; VANCOMYCIN; ANTIINFECTIVE AGENT; CYTOTOXIN; IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR; OFLOXACIN; OMEPRAZOLE;

ABDOMINAL PAIN; AGED; ARTICLE; ASCITES; BACTEREMIA; BACTERIAL INFECTION; CANCER REGRESSION; CASE REPORT; CLOSTRIDIUM DIFFICILE; COLITIS; COLON DILATATION; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISEASE SEVERITY; DRUG TREATMENT FAILURE; FECES CULTURE; HUMAN; HYPOALBUMINEMIA; HYPOTHYROIDISM; INTESTINE ULCER; LABORATORY TEST; MALE; MERKEL CELL TUMOR; NAUSEA; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; STAPHYLOCOCCUS; STEM CELL TRANSPLANTATION; DRUG EFFECT; EAR TUMOR; PSEUDOMEMBRANOUS COLITIS; SKIN TUMOR;

AGED; ANTI-BACTERIAL AGENTS; CARCINOMA, MERKEL CELL; CLOSTRIDIUM DIFFICILE; CYTOTOXINS; DIARRHEA; EAR NEOPLASMS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; METRONIDAZOLE; OFLOXACIN; OMEPRAZOLE; SKIN NEOPLASMS; THYROXINE; VANCOMYCIN;

EID: 34547097261     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2007.03.001     Document Type: Article

References (16)

1. Bartlett J.G. Narrative review: The new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 145 (2006) 758-764
2. Kelly C.P., Pothoulakis C., and LaMont J.T. Clostridium difficilecolitis. N Engl J Med 330 (1994) 257-262
3. Karlstrom O., Fryklund B., Tullus K., Burman L.G., and Swedish C. difficile Study Group. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. Clin Infect Dis 26 (1998) 141-145
4. [published correction appears in N Eugl J Med. 2006; 354:2200]. Loo V.G., Poirier L., Miller M.A., et al. A predominantly clonal multi-institutional outbreak of Clostridium difficileassociated diarrhea with high morbidity and mortality. N Engl J Med 353 (2005) 2442-2449
5. Muto C.A., Pokrywka M., Shutt K., et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 26 (2005) 273-280
6. Pepin J., Valiquette L., Alary M.E., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: A changing pattern of disease severity. CMAJ 171 (2004) 466-472
7. Musher D.M., Aslam S., Logan N., et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 40 (2005) 1586-1590
8. Aslam S., Hamill R.J., and Musher D.M. Treatment of Clostridium difficile-associated disease: Old therapies and new strategies. Lancet Infect Dis 5 (2005) 549-557
9. Kelly C.P. Immune response to Clostridium difficile infection. Eur J Gastroenterol Hepatol 8 (1996) 1048-1053
10. Warny M., Vaerman J.P., Avesani V., and Delmee M. Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun 62 (1994) 384-389
11. Salcedo J., Keates S., Pothoulakis C., et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut 41 (1997) 366-370
12. Giannasca P.J., and Warny M. Active and passive immunization against Clostridium difficile diarrhea and colitis. Vaccine 22 (2004) 848-856
13. McPherson S., Rees C.J., Ellis R., et al. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea. Dis Colon Rectum 49 (2006) 640-645
14. Wilcox M.H. Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea. J Antimicrob Chemother 53 (2004) 882-884
15. Murphy C., Vernon M., and Cullen M. Intravenous immunoglobulin for resistant Clostridium difcile infection. Age Ageing 35 (2006) 85-86
16. Boulis A., Goold S., and Ubel P.A. Responding to the immunoglobulin shortage: A case study. J Health Polit Policy Lam 27 (2002) 977-999